The Role of Tetraspanin CD37 in B-Cell Malignancy

被引：0
|
作者：
Beckwith, Kyle A. [1 ]
Williams, Erich I. [2 ]
Wright, Mark D. [3 ]
van Spriel, Annemiek B. [4 ]
Byrd, John C. [2 ,5 ]
Muthusamy, Natarajan [2 ,6 ]
机构：
[1] Ohio State Univ, Dept Med, Div Hematol, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA
[3] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia
[4] Radboud Univ Nijmegen, Med Ctr, Inst Mol Life Sci, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands
[5] Ohio State Univ, Coll Pharm, Div Med Chem, Columbus, OH 43210 USA
[6] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Germinal centres: role in B-cell physiology and malignancy
    Klein, Ulf
    Dalla-Favera, Riccardo
    NATURE REVIEWS IMMUNOLOGY, 2008, 8 (01) : 22 - 33
  • [42] Germinal centres: role in B-cell physiology and malignancy
    Ulf Klein
    Riccardo Dalla-Favera
    Nature Reviews Immunology, 2008, 8 : 22 - 33
  • [43] CD37 and CD44 evaluation by flow cytometry: can these markers improve B cell lymphoma characterization?
    Chaffin, Joanna
    Mostofizadeh, Sayedamin
    Seifert, Robert
    JOURNAL OF HEMATOPATHOLOGY, 2021, 14 (03) : 187 - 196
  • [44] IMPROVED EFFICACY OF MAB 37.1, A NOVEL FC-ENGINEERED CD37 ANTIBODY, IN COMBINATION WITH CHEMOTHERAPY AND RITUXIMAB IN MODELS OF B-CELL LYMPHOMA
    Heider, K. H.
    Baum, A.
    Schweiger, I.
    Rodi, N.
    Ruzicka, R.
    Adolf, G.
    Borges, E.
    HAEMATOLOGICA, 2012, 97 : 437 - 437
  • [45] The Tetraspanin CD37 Orchestrates the α4β1 Integrin-Akt Signaling Axis and Supports Long-Lived Plasma Cell Survival
    van Spriel, Annemiek B.
    de Keijzer, Sandra
    van der Schaaf, Alie
    Gartlan, Kate H.
    Sofi, Mariam
    Light, Amanda
    Linssen, Peter C.
    Boezeman, Jan B.
    Zuidscherwoude, Malou
    Reinieren-Beeren, Inge
    Cambi, Alessandra
    Mackay, Fabienne
    Tarlinton, David M.
    Figdor, Carl G.
    Wright, Mark D.
    SCIENCE SIGNALING, 2012, 5 (250)
  • [46] CD37 expression in follicular lymphoma
    Takuro Yoshimura
    Hiroaki Miyoshi
    Joji Shimono
    Kazutaka Nakashima
    Mai Takeuchi
    Eriko Yanagida
    Kyohei Yamada
    Yasumasa Shimasaki
    Mayuko Moritsubo
    Takuya Furuta
    Kei Kohno
    Koichi Ohshima
    Annals of Hematology, 2022, 101 : 1067 - 1075
  • [47] Staining the target: CD37 expression in lymphomas
    Bertoni, Francesco
    Stathis, Anastasios
    BLOOD, 2016, 128 (26) : 3022 - 3023
  • [48] CD37 and CD44 evaluation by flow cytometry: can these markers improve B cell lymphoma characterization?
    Joanna Chaffin
    Sayedamin Mostofizadeh
    Robert Seifert
    Journal of Hematopathology, 2021, 14 : 187 - 196
  • [49] Novel CD37, Humanized CD37 and Bi-Specific Humanized CD37-CD19 CAR-T Cells Specifically Target Lymphoma
    Golubovskaya, Vita
    Zhou, Hua
    Li, Feng
    Valentine, Michael
    Sun, Jinying
    Berahovich, Robert
    Xu, Shirley
    Quintanilla, Milton
    Ma, Man Cheong
    Sienkiewicz, John
    Huang, Yanwei
    Wu, Lijun
    CANCERS, 2021, 13 (05) : 1 - 14
  • [50] DELIVERY OF SAPORIN TO HUMAN B-CELL LYMPHOMA USING BISPECIFIC ANTIBODY - TARGETING VIA CD22 BUT NOT CD19, CD37, OR IMMUNOGLOBULIN RESULTS IN EFFICIENT KILLING
    BONARDI, MA
    FRENCH, RR
    AMLOT, P
    MODENA, D
    GLENNIE, MJ
    CANCER RESEARCH, 1993, 53 (13) : 3015 - 3021
12345